Leukemia, Myelodysplasia, Transplantation
News
Experimental Ibrutinib Could Change Treatment of CLL
Major Finding: Ibrutinib monotherapy produced an overall response rate of 68% in previously untreated patients and 71% in patients with relapsed...
News
HEM-ONC CHAT: Dr. James N. George, 'Keep At It'
Commentary
ASH12: Apixaban cuts risk of venous thromboembolism
Video
HEM-ONC CHAT: What Research Area is on Top of Your Agenda?
News
Late Leukemia Risk Rises after Breast Cancer Therapy
Major Finding: The 10-year incidence of leukemia after adjuvant chemotherapy for breast cancer appears to hover around 0.5%, twice as high as...
News
Melanoma Treatment With Vemurafenib Can Trigger Leukemia
Reviews
Dasatinib in the first-line treatment of chronic myeloid leukemia
News
FDA Approves Omacetaxine for Chronic Myeloid Leukemia
News
ASRM: Egg Freezing No Longer 'Experimental'
News
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
News
FDA approves 3rd-generation TKI for CML
Bosutinib is intended for use in patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive CML who have failed therapy...